Inozyme Pharma Inc (INZY)

Inozyme Pharma Inc Azioni (INZY) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	6.74% 24.34	22.81	18.07	16.39	18.37
Interest Income/Expense	1.325	-	-	-	-
Depreciation and Amortization	3.41% 0.182	0.176	0.208	0.209	0.207
Operating Income/Loss	6.74% -24.34	-22.81	-18.07	-16.39	-18.37
Nonoperating Income/Loss	21.04% 0.998	1.264	1.436	0.811	0.965
Income/Loss From Continuing Operations Before Tax	8.37% -23.35	-21.54	-16.64	-15.58	-17.40
Income/Loss From Continuing Operations After Tax	8.37% -23.35	-21.54	-16.64	-15.58	-17.40
Net Income/Loss	8.37% -23.35	-21.54	-16.64	-15.58	-17.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,747% 61.77	3.345	56.76	44.86	43.72
Diluted Average Shares	1,747% 61.77	3.345	56.76	44.86	43.72
Basic Earnings Per Share	8.57% -0.38	-0.35	-0.29	-0.35	-0.40
Diluted Earnings Per Share	8.57% -0.38	-0.35	-0.29	-0.35	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-